Anti-VEGF Agents for the Treatment of Pigment Epithelial Detachments Associated with Neovascular Age-related Macular Degeneration: An Evidence-based Approach.
作者信息
Panos Georgios D, Gatzioufas Zisis
机构信息
Department of Ophthalmology, Geneva University Hospitals, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Department of Ophthalmology, Geneva University Hospitals, Faculty of Medicine, University of Geneva, Geneva, Switzerland ; Moorfields Eye Hospital, London, UK.
出版信息
Med Hypothesis Discov Innov Ophthalmol. 2015 Winter;4(4):127-129.
Abstract
摘要
相似文献
1
Anti-VEGF Agents for the Treatment of Pigment Epithelial Detachments Associated with Neovascular Age-related Macular Degeneration: An Evidence-based Approach.抗血管内皮生长因子药物治疗与新生血管性年龄相关性黄斑变性相关的色素上皮脱离：循证医学方法
Med Hypothesis Discov Innov Ophthalmol. 2015 Winter;4(4):127-129.
2
OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.新生血管性年龄相关性黄斑变性患者的色素上皮脱离的最佳处理。
Retina. 2018 Nov;38(11):2103-2117. doi: 10.1097/IAE.0000000000002195.
3
Serous Index of Pigment Epithelial Detachments in Neovascular Age-Related Macular Degeneration Predicts Response to Anti-Vascular Endothelial Growth Factor Treatment.新生血管性年龄相关性黄斑变性中色素上皮脱离的浆液性指数可预测抗血管内皮生长因子治疗的反应。
Ophthalmic Surg Lasers Imaging Retina. 2015 Jul-Aug;46(7):724-7. doi: 10.3928/23258160-20150730-06.
4
[Subretinal hemorrhage after intravitreal injection of anti-VEGF for age-related macular degeneration: a retrospective study].玻璃体内注射抗血管内皮生长因子治疗年龄相关性黄斑变性后视网膜下出血：一项回顾性研究
J Fr Ophtalmol. 2009 May;32(5):309-13. doi: 10.1016/j.jfo.2009.04.001. Epub 2009 May 17.
5
Imaging characteristics of neovascular pigment epithelial detachments and their response to anti-vascular endothelial growth factor therapy.新生血管性色素上皮脱离的影像学特征及其对抗血管内皮生长因子治疗的反应。
Br J Ophthalmol. 2013 Aug;97(8):1024-31. doi: 10.1136/bjophthalmol-2013-303155. Epub 2013 Jun 12.
6
Indocyanine green videoangiographic findings in detachment of the retinal pigment epithelium.视网膜色素上皮脱离的吲哚菁绿视频血管造影检查结果
Ophthalmology. 1995 Apr;102(4):622-9. doi: 10.1016/s0161-6420(95)30990-6.
7
TYPE 1 VERSUS TYPE 3 NEOVASCULARIZATION IN PIGMENT EPITHELIAL DETACHMENTS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: A Prospective Study.抗血管内皮生长因子治疗后年龄相关性黄斑变性相关色素上皮脱离中1型与3型新生血管形成的前瞻性研究
Retina. 2016 Dec;36 Suppl 1:S50-S64. doi: 10.1097/IAE.0000000000001271.
8
Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment.雷珠单抗和贝伐单抗交替双周玻璃体内注射治疗伴有色素上皮脱离的难治性新生血管性年龄相关性黄斑变性
Semin Ophthalmol. 2017;32(3):309-315. doi: 10.3109/08820538.2015.1072222. Epub 2015 Sep 4.
9
Comparison of anti-VEGF therapies on fibrovascular pigment epithelial detachments in age-related macular degeneration.抗VEGF疗法对年龄相关性黄斑变性中纤维血管性色素上皮脱离的疗效比较
Br J Ophthalmol. 2017 Jul;101(7):970-975. doi: 10.1136/bjophthalmol-2016-309434. Epub 2016 Dec 2.
10
VOLUMETRIC ASSESSMENT OF THE RESPONSIVENESS OF PIGMENT EPITHELIAL DETACHMENTS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TO INTRAVITREAL BEVACIZUMAB.新生血管性年龄相关性黄斑变性中色素上皮脱离对玻璃体内注射贝伐单抗反应性的容积评估
Retina. 2016 Feb;36(2):264-71. doi: 10.1097/IAE.0000000000000795.
引用本文的文献
1
Longitudinal changes in pigment epithelial detachment composition indices (PEDCI): new biomarkers in neovascular age-related macular degeneration.色素上皮脱离成分指数（PEDCI）的纵向变化：新生血管性年龄相关性黄斑变性的新生物标志物。
Graefes Arch Clin Exp Ophthalmol. 2024 May;262(5):1489-1498. doi: 10.1007/s00417-023-06335-3. Epub 2023 Dec 23.
本文引用的文献
1
Ranibizumab for the treatment of degenerative ocular conditions.雷珠单抗用于治疗退行性眼部疾病。
Clin Ophthalmol. 2014 Jun 24;8:1187-98. doi: 10.2147/OPTH.S40350. eCollection 2014.
2
Visual and anatomical outcomes of intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration.玻璃体内注射阿柏西普治疗抵抗性新生血管性年龄相关性黄斑变性的临床疗效和解剖结构。
Biomed Res Int. 2014;2014:273754. doi: 10.1155/2014/273754. Epub 2014 May 7.
3
Ranibizumab treatment for choroidal neovascularization secondary to causes other than age-related macular degeneration with good baseline visual acuity.雷珠单抗治疗除年龄相关性黄斑变性以外其他原因引起的脉络膜新生血管且基线视力良好者。
Semin Ophthalmol. 2014 Mar;29(2):108-13. doi: 10.3109/08820538.2013.839716. Epub 2014 Jan 10.
4
Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration.雷珠单抗对与渗出性年龄相关性黄斑变性相关的浆液性和血管性色素上皮脱离的影响。
Drug Des Devel Ther. 2013 Jul 10;7:565-9. doi: 10.2147/DDDT.S46610. Print 2013.
5
Intravitreal ranibizumab in choroidal neovascularisation due to multifocal choroiditis and panuveitis syndrome.玻璃体内注射雷珠单抗治疗多灶性脉络膜炎和全葡萄膜炎综合征所致脉络膜新生血管
BMJ Case Rep. 2013 Jul 17;2013:bcr2013009572. doi: 10.1136/bcr-2013-009572.
6
Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab.抗血管内皮生长因子药物治疗抵抗的新生血管性年龄相关性黄斑变性患者玻璃体内注射阿柏西普后视网膜色素上皮脱离的快速消退。
Eye (Lond). 2013 May;27(5):663-7; quiz 668. doi: 10.1038/eye.2013.31. Epub 2013 Apr 5.
7
Variable response of vascularized pigment epithelial detachments to ranibizumab based on lesion subtypes, including polypoidal choroidal vasculopathy.基于病变亚型（包括息肉样脉络膜血管病变）对血管化色素上皮脱离对雷珠单抗的可变反应。
Retina. 2013 May;33(5):990-7. doi: 10.1097/IAE.0b013e3182755793.
8
Topical ranibizumab as a treatment of corneal neovascularization.局部雷珠单抗治疗角膜新生血管。
Cornea. 2013 Jul;32(7):992-7. doi: 10.1097/ICO.0b013e3182775f8d.
9
Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.年龄相关性黄斑变性中的血管化视网膜色素上皮脱离：治疗和 RPE 撕裂发生率。
Graefes Arch Clin Exp Ophthalmol. 2012 Sep;250(9):1283-92. doi: 10.1007/s00417-012-1955-2. Epub 2012 Feb 21.
10
One-year outcome after intravitreal ranibizumab for large, serous pigment epithelial detachment secondary to age-related macular degeneration.年龄相关性黄斑变性继发大的浆液性色素上皮脱离行玻璃体内雷珠单抗治疗一年的结果。
Eye (Lond). 2011 Aug;25(8):1034-8. doi: 10.1038/eye.2011.115. Epub 2011 May 20.
Zotero 插件